Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study

• Main Authors: Gwanyoung Kim (Author), Hyun-ki Moon (Author), Taeheon Kim (Author), So-hye Yun (Author), Hwi-yeol Yun (Author), Jang Hee Hong (Author), Dae-Duk Kim (Author)
• Format: Book
• Published: MDPI AG, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Camostat mesylate is expected to be promising as a treatment option for COVID-19, in addition to other indications for which it is currently used. Furthermore, in vitro experiments have confirmed the potential of camostat and its metabolites to be effective against COVID-19. Therefore, clinical tria...